These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 20946409

  • 1. Clarithromycin and amikacin vs. clarithromycin and moxifloxacin for the treatment of post-acupuncture cutaneous infections due to Mycobacterium abscessus: a prospective observational study.
    Choi WS, Kim MJ, Park DW, Son SW, Yoon YK, Song T, Bae SM, Sohn JW, Cheong HJ, Kim MJ.
    Clin Microbiol Infect; 2011 Jul; 17(7):1084-90. PubMed ID: 20946409
    [Abstract] [Full Text] [Related]

  • 2. Iatrogenic Mycobacterium abscessus infection associated with acupuncture: clinical manifestations and its treatment.
    Ryu HJ, Kim WJ, Oh CH, Song HJ.
    Int J Dermatol; 2005 Oct; 44(10):846-50. PubMed ID: 16207187
    [Abstract] [Full Text] [Related]

  • 3. An outbreak of post-acupuncture cutaneous infection due to Mycobacterium abscessus.
    Song JY, Sohn JW, Jeong HW, Cheong HJ, Kim WJ, Kim MJ.
    BMC Infect Dis; 2006 Jan 13; 6():6. PubMed ID: 16412228
    [Abstract] [Full Text] [Related]

  • 4. Skin and soft tissue infections due to rapidly growing mycobacteria: comparison of clinical features, treatment, and susceptibility.
    Uslan DZ, Kowalski TJ, Wengenack NL, Virk A, Wilson JW.
    Arch Dermatol; 2006 Oct 13; 142(10):1287-92. PubMed ID: 17043183
    [Abstract] [Full Text] [Related]

  • 5. Failure of treatment for chronic Mycobacterium abscessus meningitis despite adequate clarithromycin levels in cerebrospinal fluid.
    Maniu CV, Hellinger WC, Chu SY, Palmer R, Alvarez-Elcoro S.
    Clin Infect Dis; 2001 Sep 01; 33(5):745-8. PubMed ID: 11486298
    [Abstract] [Full Text] [Related]

  • 6. Moxifloxacin is non-inferior to combination therapy with ceftriaxone plus metronidazole in patients with community-origin complicated intra-abdominal infections.
    Solomkin J, Zhao YP, Ma EL, Chen MJ, Hampel B, DRAGON Study Team.
    Int J Antimicrob Agents; 2009 Nov 01; 34(5):439-45. PubMed ID: 19692210
    [Abstract] [Full Text] [Related]

  • 7. An outbreak of cutaneous infection due to Mycobacterium abscessus associated to mesotherapy.
    Galmés-Truyols A, Giménez-Duran J, Bosch-Isabel C, Nicolau-Riutort A, Vanrell-Berga J, Portell-Arbona M, Seguí-Prat B, Gumá-Torá M, Martí-Alomar I, Rojo-Arias MÁ, Ruiz-Veramendi M.
    Enferm Infecc Microbiol Clin; 2011 Nov 01; 29(7):510-4. PubMed ID: 21684045
    [Abstract] [Full Text] [Related]

  • 8. Moxifloxacin monotherapy is effective in hospitalized patients with community-acquired pneumonia: the MOTIV study--a randomized clinical trial.
    Torres A, Garau J, Arvis P, Carlet J, Choudhri S, Kureishi A, Le Berre MA, Lode H, Winter J, Read RC, MOTIV (MOxifloxacin Treatment IV) Study Group.
    Clin Infect Dis; 2008 May 15; 46(10):1499-509. PubMed ID: 18419482
    [Abstract] [Full Text] [Related]

  • 9. Nontuberculous mycobacterial skin infections: clinical and bacteriological studies.
    Mahaisavariya P, Chaiprasert A, Khemngern S, Manonukul J, Gengviniij N, Ubol PN, Pinitugsorn S.
    J Med Assoc Thai; 2003 Jan 15; 86(1):52-60. PubMed ID: 12678139
    [Abstract] [Full Text] [Related]

  • 10. Aerosolized amikacin and oral clarithromycin to eradicate Mycobacterium abscessus in a patient with cystic fibrosis: an 8-year follow-up.
    Colin AA, Ali-Dinar T.
    Pediatr Pulmonol; 2010 Jun 15; 45(6):626-7. PubMed ID: 20503290
    [No Abstract] [Full Text] [Related]

  • 11. Oral moxifloxacin and topical amikacin for Mycobacterium abscessus keratitis after laser in situ keratomileusis.
    Pacheco PA, Tam PM.
    J Cataract Refract Surg; 2010 May 15; 36(5):843-6. PubMed ID: 20457379
    [Abstract] [Full Text] [Related]

  • 12. [Treatment of cutaneous infections due to Mycobacterium fortuitum: two cases].
    Régnier S, Martinez V, Veziris N, Bonvallot T, Meningaud JP, Caumes E.
    Ann Dermatol Venereol; 2008 May 15; 135(8-9):591-5. PubMed ID: 18789296
    [Abstract] [Full Text] [Related]

  • 13. Nontuberculous mycobacterial infections of the skin: A retrospective study of 25 cases.
    Dodiuk-Gad R, Dyachenko P, Ziv M, Shani-Adir A, Oren Y, Mendelovici S, Shafer J, Chazan B, Raz R, Keness Y, Rozenman D.
    J Am Acad Dermatol; 2007 Sep 15; 57(3):413-20. PubMed ID: 17368631
    [Abstract] [Full Text] [Related]

  • 14. Sequential intravenous/oral moxifloxacin monotherapy for complicated skin and skin structure infections: a meta-analysis of randomised controlled trials.
    Chen F, Zheng N, Wang Y, Wen JL, Tu WF, Du YQ, Lin JM.
    Int J Clin Pract; 2013 Sep 15; 67(9):834-42. PubMed ID: 23952463
    [Abstract] [Full Text] [Related]

  • 15. Moxifloxacin-tetracycline-lansoprazole triple therapy for first-line treatment of Helicobacter pylori infection: a prospective study.
    Taş A, Akbal E, Koçak E, Köklü S.
    Helicobacter; 2011 Feb 15; 16(1):52-4. PubMed ID: 21241413
    [Abstract] [Full Text] [Related]

  • 16. Five-day moxifloxacin therapy compared with 7-day co-amoxiclav therapy for the treatment of acute exacerbation of chronic bronchitis.
    Starakis I, Gogos CA, Bassaris H.
    Int J Antimicrob Agents; 2004 Feb 15; 23(2):129-37. PubMed ID: 15013037
    [Abstract] [Full Text] [Related]

  • 17. Clinical outcome of Mycobacterium abscessus infection and antimicrobial susceptibility testing.
    Huang YC, Liu MF, Shen GH, Lin CF, Kao CC, Liu PY, Shi ZY.
    J Microbiol Immunol Infect; 2010 Oct 15; 43(5):401-6. PubMed ID: 21075707
    [Abstract] [Full Text] [Related]

  • 18. A comparison of levofloxacin and moxifloxacin use in hospitalized community-acquired pneumonia (CAP) patients in the US: focus on length of stay.
    Schein J, Janagap-Benson C, Grant R, Sikirica V, Doshi D, Olson W.
    Curr Med Res Opin; 2008 Mar 15; 24(3):895-906. PubMed ID: 18419876
    [Abstract] [Full Text] [Related]

  • 19. Clinical, microbiological, and epidemiological findings of an outbreak of Mycobacterium abscessus hand-and-foot disease.
    Dytoc MT, Honish L, Shandro C, Ting PT, Chui L, Fiorillo L, Robinson J, Fanning A, Predy G, Rennie RP.
    Diagn Microbiol Infect Dis; 2005 Sep 15; 53(1):39-45. PubMed ID: 16054324
    [Abstract] [Full Text] [Related]

  • 20. Moxifloxacin five-day therapy versus placebo in acute bacterial rhinosinusitis.
    Hadley JA, Mösges R, Desrosiers M, Haverstock D, van Veenhuyzen D, Herman-Gnjidic Z.
    Laryngoscope; 2010 May 15; 120(5):1057-62. PubMed ID: 20422704
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.